What is the Gilteritinib fumarate?

Gilteritinib fumarate is , while it's Molecular Formula is C62H92N16O10. Used in Oncology: Gilteritinib fumarate is used as an anticancer agent for the treatment of acute myeloid leukemia (AML). It is particularly effective in patients with mutations in the FLT3 gene, as it targets and inhibits the FLT3 protein, blocking the growth and proliferation of AML cells and ultimately leading to their death. Used in Drug Development: Gilteritinib fumarate is used as a research compound in the development of targeted therapies for cancer treatment. Its selective inhibition of the FLT3 protein makes it a valuable tool for studying the role of FLT3 in cancer growth and survival, as well as for evaluating the potential benefits of FLT3 inhibitors in the treatment of AML and other cancers. Used in Clinical Trials: Gilteritinib fumarate is used as a test drug in clinical trials to evaluate its safety, efficacy, and optimal dosage for the treatment of AML. These trials help to determine the best treatment protocols and patient populations for which gilteritinib fumarate is most effective, ultimately leading to its approval for use in certain patient populations. Used in Pharmaceutical Formulation: Gilteritinib fumarate is used as an active pharmaceutical ingredient in the formulation of oral medications for the treatment of AML. Its fumarate salt form enhances the solubility and bioavailability of the drug, making it more effective when administered orally, and allowing for targeted delivery to cancer cells.

What is the CAS number for Gilteritinib fumarate?

The CAS number of Gilteritinib fumarate is 1254053-84-3.

What is Gilteritinib fumarate (1254053-84-3) used for?

Gilteritinib fumarate is a potent and selective inhibitor of FLT3, a protein that plays a crucial role in the growth and survival of cancer cells, particularly in acute myeloid leukemia (AML). Its fumarate salt form enhances the solubility and bioavailability of the drug, making it more effective when administered orally. Gilteritinib fumarate works by targeting FLT3, blocking the growth and proliferation of AML cells, ultimately leading to their death. This targeted approach makes gilteritinib fumarate a promising treatment option for patients with AML who have mutations in the FLT3 gene.

What is the Gilteritinib fumarate?

Gilteritinib fumarate is , while it's Molecular Formula is C62H92N16O10. Used in Oncology: Gilteritinib fumarate is used as an anticancer agent for the treatment of acute myeloid leukemia (AML). It is particularly effective in patients with mutations in the FLT3 gene, as it targets and inhibits the FLT3 protein, blocking the growth and proliferation of AML cells and ultimately leading to their death. Used in Drug Development: Gilteritinib fumarate is used as a research compound in the development of targeted therapies for cancer treatment. Its selective inhibition of the FLT3 protein makes it a valuable tool for studying the role of FLT3 in cancer growth and survival, as well as for evaluating the potential benefits of FLT3 inhibitors in the treatment of AML and other cancers. Used in Clinical Trials: Gilteritinib fumarate is used as a test drug in clinical trials to evaluate its safety, efficacy, and optimal dosage for the treatment of AML. These trials help to determine the best treatment protocols and patient populations for which gilteritinib fumarate is most effective, ultimately leading to its approval for use in certain patient populations. Used in Pharmaceutical Formulation: Gilteritinib fumarate is used as an active pharmaceutical ingredient in the formulation of oral medications for the treatment of AML. Its fumarate salt form enhances the solubility and bioavailability of the drug, making it more effective when administered orally, and allowing for targeted delivery to cancer cells.

What is the CAS number for Gilteritinib fumarate?

The CAS number of Gilteritinib fumarate is 1254053-84-3.

What is Gilteritinib fumarate (1254053-84-3) used for?

Gilteritinib fumarate is a potent and selective inhibitor of FLT3, a protein that plays a crucial role in the growth and survival of cancer cells, particularly in acute myeloid leukemia (AML). Its fumarate salt form enhances the solubility and bioavailability of the drug, making it more effective when administered orally. Gilteritinib fumarate works by targeting FLT3, blocking the growth and proliferation of AML cells, ultimately leading to their death. This targeted approach makes gilteritinib fumarate a promising treatment option for patients with AML who have mutations in the FLT3 gene.

Products

Product classification

small-molecule inhibitor
intermediate
Pharmaceutical intermediate
Biochemical reagent
fire retardant
chemical reagent
ionic liquid
Inhibitor
Antibody
Pesticide
New materials
Customization
Nucleosides
Food additives
Supplement
API
Pharmaceutical intermediates

Contact us

Tel：+86-0533-2185556
Fax：+86-0533-2185556
Phone：WhatsApp: +86 15965530500
Website：https://www.shandonghangyubiotech.com
Email：admin@hangyubiotech.com
Address：Room 2516, Dingcheng Building, Beijing Road, Zhangdian District, Zibo City, Shandong Province

1254053-84-3

Product Name:Gilteritinib hemifumarate)
Molecular Formula:C62H92N16O10
Molecular Weight:1221.5

Inquiry

Product Details

Purity:99%

Top quality factory supply 1254053-84-3 Gilteritinib hemifumarate) at low price

Molecular Formula:C62H92N16O10
Molecular Weight:1221.5

Relevant Products

JORO SPIDER TOXIN JSTX-3
CAS：112163-33-4
cis-13-Docosenoamide
CAS：112-84-5
1-bromotriacontane
CAS：4209-22-7
2,2-methylenebisfuran
CAS：1197-40-6

Home

About us

Products

small-molecule inhibitor

intermediate

Pharmaceutical intermediate

Biochemical reagent

fire retardant

chemical reagent

ionic liquid

Inhibitor

Antibody

Pesticide

New materials

Customization

Nucleosides

Food additives

Supplement

API

Pharmaceutical intermediates

Biological products

Polypeptides

Chemical reagents

Small molecule inhibitors

Organic electronic chemical materials

Technical Support

News

Contact Us